| Code | Name | Last | Change(%) | P/E | Yield (%) | P/E Range | ||
| INAB | IN8bio Inc |  | 1.78 | -9.18% | -- | -- | ||
| Pre Market |  | -- | -- | |||||
| IBRX | ImmunityBio | | 2.09 | -9.13% | -- | -- | ||
| Pre Market | | 2.08 | -0.48% | |||||
| ACRV | Acrivon Therapeutics | | 2.2 | -9.09% | -- | -- | ||
| Pre Market | | 2.2 | 0.00% | |||||
| ALXO | ALX Oncology Holdings | | 1.2 | -9.09% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| EWTX | Edgewise Therapeutics | | 22.98 | -9.06% | -- | -- | ||
| Pre Market |  | 23.01 | +0.13% | |||||
| STRO | Sutro Biopharma | | 0.7298 | -8.95% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| CBUS | Cibus | | 1.34 | -8.84% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| CHRS | Coherus Oncology Inc | | 1.16 | -8.66% | 2.31 | -- |  | |
| Pre Market | | 1.11 | -4.31% | |||||
| RLMD | Relmada Therapeutics | | 4.04 | -8.60% | -- | -- | ||
| Pre Market | | 3.91 | -3.22% | |||||
| MNPR | Monopar Therapeutics Inc | | 75.94 | -8.57% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| BDTX | Black Diamond Therapeutics | | 3.45 | -8.49% | 15.71 | -- | | |
| Pre Market | | 3.63 | +5.22% | |||||
| GRDX | GridAI Technologies Corp | | 2.27 | -8.47% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| CLYM | Climb Bio Inc | | 1.64 | -8.38% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| TSHA | Taysha Gene Therapies | | 4.06 | -8.35% | 2.44 | -- | | |
| Pre Market | | -- | -- | |||||
| CBIO | Crescent Biopharma Inc | | 13.09 | -8.27% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| SKYE | Skye Bioscience | | 1.11 | -8.26% | 3.58 | -- | | |
| Pre Market | | 1.12 | +0.90% | |||||
| ACET | Adicet Bio | | 0.5601 | -8.23% | -- | 15.18 | ||
| Pre Market | | -- | -- | |||||
| ITRM | Iterum Therapeutics plc | | 0.414 | -8.20% | -- | -- | ||
| Pre Market | | 0.41 | -0.97% | |||||
| CYBN | Cybin Inc | | 5.51 | -8.17% | -- | -- | ||
| Pre Market | | 5.62 | +2.00% | |||||
| JSPR | Jasper Therapeutics | | 1.58 | -8.14% | -- | -- | ||
| Pre Market | | 1.46 | -7.59% | |||||
 | Quotes are at least 15-min delayed：2025/12/03 06:19 EDT |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |